You are viewing: US Precision Biotics Market analysis
Part of: Precision Biotics Market (Global)

The US Precision Biotics Market was valued at $1632.7 Million in 2026 and projected to reach to $3163.3 Million by 2031, representing a compound annual growth rate of 14.1%. The US Precision Biotics Market is positioned for sustained growth through 2031, driven by convergence of consumer wellness trends, technological innovation, and healthcare provider adoption.

US Precision Biotics Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Precision Biotics Market Trends and Insights

  • The US market is driven by rising consumer demand for personalized nutrition solutions and advancing genomic technologies that enable targeted probiotic formulations.
  • In the US, regulatory clarity and strong healthcare infrastructure support rapid adoption of precision biotic products across both consumer and clinical segments. The US precision biotics sector benefits from significant investment in microbiome research and a growing consumer base prioritizing preventive health.
  • By 2031, the US market is expected to nearly double in value, reflecting the country's leadership in biotechnology innovation and consumer willingness to adopt science-backed wellness solutions.
  • The US competitive landscape features both established nutraceutical companies and emerging biotech firms developing strain-specific and personalized probiotic interventions..

Key Market Statistics

  • CAGR (2026-2031) 14.1% CAGR
  • Market Size, 2026 ~USD 1632.7 Million
  • Forecast, 2031 ~USD 3163.3 Million
  • Country US

US Precision Biotics Market Overview

Market Valuation Growth :

The US Precision Biotics Market is valued at $1,632.7 million in 2026 and is projected to reach $3,163.3 million by 2031, representing a robust 14.1% CAGR over the forecast period.

Personalized Nutrition Demand :

US consumers are increasingly seeking personalized nutrition solutions tailored to individual genomic profiles, driving adoption of precision probiotic formulations that address specific health needs and microbiome composition.

Genomic Technology Advancement :

Cutting-edge genomic sequencing and microbiome analysis technologies are enabling US manufacturers to develop targeted probiotic products with enhanced efficacy, supporting market differentiation and premium pricing strategies.

Regulatory & Healthcare Support :

Strong US regulatory frameworks, FDA oversight clarity, and advanced healthcare infrastructure create a favorable environment for precision biotech innovation and accelerated market penetration across consumer and clinical segments.

US Precision Biotics Market Dynamics

  • Personalized medicine adoption in the US healthcare system is accelerating, with precision probiotics gaining traction among health-conscious consumers and clinical practitioners seeking evidence-based microbiome interventions.
  • The market will benefit from increasing direct-to-consumer genomic testing, integration with digital health platforms, and growing insurance coverage for personalized nutrition therapies.
  • Competitive intensity will drive product innovation and clinical validation, establishing precision biotics as a mainstream segment within the broader US probiotics and functional foods industry..

Related Ecosystem

Nutraceuticals And Dietary Supplements

Top Technologies
  • Dairy Products
  • Animal-Based Sealants
  • Carbohydrates
  • Porcine
  • Acrylic Polymers
Top Companies
  • AZELIS HOLDINGS SA
  • Amway
  • Nestle s.a
  • Kerry Group plc
  • Basf se

    Key Takeaways

    • The US Precision Biotics Market will nearly double from $1,632.7M (2026) to $3,163.3M (2031), growing at a 14.1% CAGR.
    • The US leads in precision biotic adoption due to advanced genomic capabilities and strong regulatory frameworks supporting innovation.
    • The US market is fueled by consumer demand for personalized nutrition and preventive health solutions backed by microbiome science.
    • The US competitive environment combines established nutraceutical players with innovative biotech startups developing strain-specific formulations.

    Precision Biotics Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment NEXT-GENERATION PROBIOTICS (Type)
    Forecast Period 2026-2031
    Growth Rate CAGR of 13.5% from 2026 to 2031
    Largest Segment HUMAN (End User)
    Market Size Base Year (Billions) ~USD 4.92 (2026)
    Revenue Forecast (Billions) ~USD 9.26 (2031)
    Segments Covered Type, End-Use Industry, Distribution Channel, Health/Functional Positioning, Health & Functional Positioning, Application, Type 2026-2031, Ingredient, End User

    US Precision Biotics Market Report Segmentation

    9 segment dimensions are covered across the global market.

    By Type

    • Next-Generation Probiotics
    • Postbiotics
    • Precision Probiotics
    • Synbiotics

    By End-Use Industry

    • Animal Feed
    • Cosmetics
    • Dietary Supplements
    • Functional Food & Beverages
    • Infant Formula
    • Pet Supplements
    • Pharmaceutical (Otc)

    By Distribution Channel

    • Dtc Subscription Platforms
    • E-Commerce
    • Pharmacies
    • Retail
    • Specialty Stores

    By Health/Functional Positioning

    • Digestive & Gastrointestinal Health
    • Gut & Brain Health
    • Immune Health
    • Metabolic Health
    • Oral & Dental Health
    • Pediatric & Infant Health
    • Skin Health
    • Women'S Health

    By Health & Functional Positioning

    • Digestive & Gastrointestinal Health
    • Gut & Brain Health
    • Immune Health
    • Metabolic Health
    • Oral & Dental Health
    • Pediatric & Infant Health
    • Skin Health
    • Women'S Health

    By Application

    • Next-Generation Probiotics
    • Postbiotics
    • Precision Probiotics
    • Synbiotics

    By Type 2026-2031

    • Next-Generation Probiotics
    • Postbiotics
    • Precision Probiotics
    • Synbiotics

    By Ingredient

    • Bacteria
    • Yeast

    By End User

    • Animal
    • Human

    Target Audience

    • Probiotic & Supplement Manufacturers : US-based and international manufacturers need market sizing, growth forecasts, and consumer trend data to develop precision probiotic product lines, optimize formulations, and capture market share in the expanding personalized nutrition segment.
    • Healthcare & Wellness Companies : Hospitals, clinics, and wellness providers require US market intelligence to integrate precision biotics into clinical protocols, justify reimbursement strategies, and differentiate service offerings in personalized medicine.
    • Investment & Private Equity Firms : Investors evaluating precision biotech opportunities need validated US market data, growth projections, and competitive analysis to assess investment returns, identify acquisition targets, and support portfolio company scaling strategies.
    • Retail & Distribution Partners : US retailers, e-commerce platforms, and distributors require market forecasts and consumer demand insights to optimize inventory, negotiate supplier terms, and position precision probiotic products effectively across channels.
    • Research & Consulting Professionals : Market researchers, consultants, and analysts need comprehensive US precision biotics data to support client advisory work, competitive benchmarking, and strategic recommendations in the personalized nutrition and functional foods sectors.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise US market valuation ($1,632.7M in 2026) and verified forecast data ($3,163.3M by 2031) to support investment decisions, business planning, and competitive positioning in the high-growth precision biotics segment.
    • US-Specific Consumer Insights : Access detailed analysis of US consumer demand drivers, including personalized nutrition preferences, genomic testing adoption rates, and demographic segments most receptive to precision probiotic products.
    • Regulatory & Compliance Framework : Understand US FDA regulations, labeling requirements, and healthcare infrastructure advantages specific to precision biotics, enabling compliant product development and market entry strategies tailored to American standards.
    • Competitive Landscape Intelligence : Identify leading US manufacturers, emerging startups, distribution channels, and partnership opportunities within the precision biotics ecosystem to inform competitive strategy and market expansion initiatives.
    • Technology & Innovation Trends : Discover cutting-edge genomic sequencing technologies, microbiome analysis platforms, and digital health integrations driving US market innovation, enabling strategic R&D investments and product differentiation.

    Frequently asked questions

    What is the current size of the US Precision Biotics Market?

    The US Precision Biotics Market is valued at $1,632.7 million in 2026 and is projected to grow to $3,163.3 million by 2031.

    What is the growth rate of the US Precision Biotics Market?

    The US Precision Biotics Market is expected to grow at a compound annual growth rate (CAGR) of 14.1% from 2026 to 2031.

    What drives growth in the US Precision Biotics Market?

    Growth in the US market is driven by increasing consumer demand for personalized nutrition, advances in genomic sequencing, microbiome research investments, and regulatory support for precision health solutions.

    Who are the key players in the US Precision Biotics Market?

    The US market includes established nutraceutical companies, pharmaceutical firms, and emerging biotech startups developing strain-specific and personalized probiotic formulations.

    What segments comprise the US Precision Biotics Market?

    The US market encompasses consumer wellness products, clinical/therapeutic applications, and personalized probiotic solutions tailored to individual microbiome profiles.

    RESEARCH METHODOLOGY

    This study employed two primary approaches to estimate the current size of the precision biotics market. Exhaustive secondary research was carried out to collect information on the precision biotics type, end-user industry, health/functional positioning, distribution channel, and region. The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.

    Secondary Research

    This research study used extensive secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, agriculture and precision biotics-related journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the precision biotics market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides. Primary data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as chief experience officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, and related key executives from distributors and key opinion leaders.

    Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to precision biotics type, end-use industry, health/functional positioning, distribution channel, and region. Stakeholders from the demand side, including consumers, healthcare professionals, gastroenterologists, dietitians, nutritionists, functional medicine practitioners, hospitals and specialty clinics, pharmacies, e-commerce retailers, health & wellness retailers, and personalized nutrition platforms, were interviewed to understand buyers' perspectives on product efficacy, brand preferences, purchasing behavior, distribution channels, pricing trends, and the future outlook of the precision biotics market.

    Breakdown of Primary Interviews

    Precision Biotics Market Size, and Share

    Note: The three tiers of the companies are defined based on their total revenues in 2023 or 2024, based on the availability of financial data: Tier 1: Revenue >USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue <USD 100 million.


    COMPANY

    DESIGNATION

    BioGaia (Sweden)

    Regional Sales Manager

    Pendulum (US)

    Marketing Manager

    Seed Health, Inc (US)

    General Manager

    Infinant Health Inc (US)

    Sales Manager

    thegoodbug (India)

    Sales Manager

    Symrise (Germany)- (Probi)

    Sales Executive

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The top-down and bottom-up approaches were used to estimate and validate the total size of the precision biotics market. These approaches were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following details:

    • The key players in the industry and the overall markets were identified through extensive secondary research.
    • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
    • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
    • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

    Precision Biotics Market: Top-Down and Bottom-Up Approach

    Precision Biotics Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall precision biotics market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.

     
     

    Market Definition

    The precision biotics market encompasses the development, manufacturing, distribution, and commercialization of targeted microbiome-based products designed to deliver specific health benefits using scientifically validated probiotic strains and personalized formulations. Leveraging microbiome science, AI, genomics, and multi-omics technologies, these products support applications such as digestive, metabolic, immune, gut-brain, skin, women's, pediatric, and oral health.

    The market is driven by the growing demand for personalized nutrition, increasing prevalence of chronic diseases, expanding microbiome research, and advancements in precision health technologies. Rising consumer awareness of preventive healthcare and the availability of clinically validated strain-specific probiotic products continue to support the global growth of the precision biotics market.

    Key Stakeholders

    • Supply-side: Precision biotics manufacturers, probiotic strain developers, microbiome sequencing companies, ingredient suppliers, contract development and manufacturing organizations (CDMOs), packaging providers, distributors, and logistics partners
    • Demand-side: Consumers, pharmacies, e-commerce retailers, health & wellness stores, hospitals, specialty clinics, gastroenterologists, dietitians, nutritionists, functional medicine practitioners, and personalized nutrition platforms adopting precision biotics for targeted health management
    • Regulatory side: Food safety authorities, pharmaceutical regulatory agencies, dietary supplement regulatory bodies, quality assurance organizations, and standards agencies overseeing probiotic safety, health claims, clinical evidence, labeling, and manufacturing compliance
    • Associations and industry bodies:
      • European Food Safety Authority (EFSA)
      • World Health Organization (WHO)
      • US Food and Drug Administration (USFDA)
      • Food Safety and Standards Authority of India (FSSAI)
      • Food and Agriculture Organization (FAO)
      • International Scientific Association for Probiotics and Prebiotics (ISAPP)
      • International Probiotics Association (IPA)
      • Consumer Healthcare Products Association (CHPA)

    Report Objectives

    • To determine and project the size of the precision biotics market based on type, end-use industry, health/functional positioning, distribution channel, and region over the forecast period
    • To identify key growth opportunities by analyzing the largest and fastest-growing segments across regions
    • To provide detailed insights on factors influencing market growth, including drivers, restraints, opportunities, and challenges
    • To evaluate market opportunities for stakeholders and present the competitive landscape of leading players
    • To analyze micro-markets with respect to individual growth trends, future potential, and their contribution to the overall market
    • To identify and profile key companies operating in the precision biotics market
    • To assess the competitive environment and highlight key strategies adopted by major players across regions

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolio of each company.

    Segmental Analysis

    • With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

      • Further breakdown of the Rest of Europe precision biotics market into key countries
      • Further breakdown of the Rest of Asia Pacific precision biotics market into key countries

    Company Information

    • Detailed analyses and profiling of additional market players (up to five)

    Get the Full Precision Biotics Market Report

    Full forecast, segment splits, and company analysis for all Precision Biotics Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status